Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial

J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e62-e66. doi: 10.1111/jdv.17623. Epub 2021 Aug 30.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Alopecia* / drug therapy
  • Double-Blind Method
  • Female
  • Hair
  • Humans
  • Male
  • Minoxidil*
  • Treatment Outcome

Substances

  • Minoxidil